Last reviewed · How we verify
NCT04236830
Silver Diamine Fluoride/ Potassium Iodide in Indirect Pulp Capping of Young Permanent Molars
Phase 2, PHASE3 trial testing Silver diamine fluoride/ potassium iodide in Tertiary Dentine in 108 participants. Completed in 25 March 2021.
1 March 2021
Quick facts
| Lead sponsor | Nourhan M.Aly |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 108 |
| Start date | 1 November 2019 |
| Primary completion | 1 March 2021 |
| Estimated completion | 25 March 2021 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Silver diamine fluoride/ potassium iodide
- Silver diamine fluoride — full drug profile →
- Resin modified glass ionomer cement — full drug profile →
Conditions studied
- Tertiary Dentine — all drugs for Tertiary Dentine →
- Indirect Pulp Capping — all drugs for Indirect Pulp Capping →
Sponsor
Nourhan M.Aly — full company profile →
Who can join
Adults 6 to 9, any sex, with Tertiary Dentine or Indirect Pulp Capping. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate and compare the clinical effectiveness of 38% silver diamine fluoride with and without potassium iodide with that of resin modified glass ionomer cement in indirect pulp capping of young permanent molars.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Twelve-month randomized controlled trial of 38% silver diamine fluoride with or without potassium iodide in indirect pulp capping of young permanent molars.
Baraka M, Tekeya M, Bakry NS, Fontana M. · · 2022 · cited 12× · PMID 36253166 · DOI 10.1016/j.adaj.2022.08.008
Verify or expand the search:
- PubMed search for NCT04236830
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nourhan M.Aly trials
Trials by the same sponsor.
- NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
- NCT06146296 — THE EFFECT OF VITAMIN C ON POST-ORTHODONTIC TREATMENT RELAPSE · Phase 2, PHASE3 · unknown
- NCT05811728 — Three-dimensional Assessment of the Bone Changes Accompanying Laser-assisted Orthodontic Tooth Movement · NA · completed
- NCT06352658 — Efficacy of Different Treatments for Obstructive Sleep Apnea · NA · completed
- NCT05782088 — Single Versus Repeated Piezocision-assisted Orthodontic Tooth Movement · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236830 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nourhan M.Aly
- Last refreshed: 19 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236830.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing